Staci Ann Gruber is an Associate Professor of Psychiatry at Harvard Medical School and Director of the Cognitive and Clinical Neuroimaging Core (CCNC) and the Marijuana Investigation for Neuroscientific Discovery (MIND) Program.
[2] As of 2022 she is an Associate Professor of Psychiatry at Harvard Medical School and the director of the Marijuana Investigations for Neuroscientific Discovery (MIND) Program at McLean Hospital.
[4][5] Dr. Gruber’s earlier work focused on the application of neurocognitive models and brain imaging to better characterize neurobiological risk factors for psychopathology; she is a co-author on some of the first published findings in patients with psychotic disorders using proton MRS and fMRI techniques.
[9][10] MIND examines the impact of medical cannabis using observational, longitudinal, and survey studies, as well as clinical trials of cannabinoid-based products.
[12] Some of her research is conducted with private funding due to the federal government's placement of cannabis in Schedule I, having no accepted medical use.